Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

Survivin is a member of the inhibitor of apoptosis protein (IAP) family containing a single baculovirus IAP repeat domain. It is expressed during fetal development but becomes undetectable in terminally differentiated normal adult tissues. We previously reported that survivin and its splicing varian...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuruma, Tetsuhiro, Hata, Fumitake, Torigoe, Toshihiko, Furuhata, Tomohisa, Idenoue, Satomi, Kurotaki, Takehiro, Yamamoto, Masaaki, Yagihashi, Atsuhito, Ohmura, Tosei, Yamaguchi, Koji, Katsuramaki, Tadashi, Yasoshima, Takahiro, Sasaki, Kazuaki, Mizushima, Yasuhiro, Minamida, Hidetoshi, Kimura, Hiromichi, Akiyama, Morifumi, Hirohashi, Yoshihiko, Asanuma, Hiroko, Tamura, Yasuaki, Shimozawa, Kumiko, Sato, Noriyuki, Hirata, Koichi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC446218/
https://www.ncbi.nlm.nih.gov/pubmed/15193151
http://dx.doi.org/10.1186/1479-5876-2-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC446218/
https://www.ncbi.nlm.nih.gov/pubmed/15193151
http://dx.doi.org/10.1186/1479-5876-2-19

Ejemplares similares